ICON PLC — Investor Relations & Filings
ICON PLC is a global provider of outsourced development and commercialization services for the pharmaceutical, biotechnology, and medical device sectors. The company supports clients in accelerating the development of drugs and devices, offering a comprehensive suite of services that span the entire clinical lifecycle from "molecule to medicine." Core capabilities include consulting, early clinical and bioanalytical solutions, site and patient solutions, specialty laboratory services supporting precision medicine, and market access strategies covering pricing and reimbursement. ICON also delivers specialized biotech support, such as due diligence and asset valuation, alongside advanced cardiac safety solutions. The company integrates healthcare intelligence and technology, including artificial intelligence, to enhance clinical research processes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - ICON PLC (0001060955) (Filer) | 2026-04-29 | English | |
| 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | |
| 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | |
| 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | |
| 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | |
| 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 38523041 | 6-K - ICON PLC (0001060955) (Filer) | 2026-04-29 | English | ||
| 32979428 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32979257 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32979034 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32979027 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32978975 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32979000 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32978992 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32978823 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32979004 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 27010870 | 6-K Filing | 2026-01-07 | English | ||
|
2025
4 filings
| |||||
| 11036694 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 11036695 | Major Shareholding Notification 2025 | 2025-11-12 | English | ||
| 11036696 | 6-K | 2025-11-12 | English | ||
| 11036697 | Regulatory Filings 2025 | 2025-11-03 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for ICON PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Flydoo Technology Holding Limited
Provides comprehensive travel services, package tours, and …
|
8069 | HK | Professional, scientific and te… |
|
Foghorn Therapeutics Inc.
Develops medicines targeting the chromatin regulatory syste…
|
FHTX | US | Professional, scientific and te… |
|
Formosa Pharmaceuticals, Inc.
Develops ophthalmology and oncology therapies using proprie…
|
6838 | TW | Professional, scientific and te… |
|
Fortrea Holdings Inc.
A global CRO providing clinical development and patient acc…
|
FTRE | US | Professional, scientific and te… |
|
Foxtron Vehicle Technologies Co., Ltd.
Specializes in electric vehicle design, open platforms, and…
|
2258 | TW | Professional, scientific and te… |
|
Frontage Holdings Corporation
Global CRO offering integrated services for drug discovery,…
|
1521 | HK | Professional, scientific and te… |
|
FUNCTIONAL TECHNOLOGIES CORP.
Developed proprietary, advanced yeast-based solutions for t…
|
FEB | CA | Professional, scientific and te… |
|
FUSION ANTIBODIES PLC
CRO providing end-to-end services for preclinical antibody …
|
FAB | GB | Professional, scientific and te… |
|
GEMPHARMATECH CO., LTD.
Provides genetically engineered mouse models and preclinica…
|
688046 | CN | Professional, scientific and te… |
|
Genenta Science S.p.A.
Clinical-stage developer of hematopoietic stem cell gene th…
|
GNTA | IT | Professional, scientific and te… |
ICON PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30483/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30483 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30483 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30483 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30483}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ICON PLC (id: 30483)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.